Please login to bookmark Close

Medical device maker Bayer has successfully defended a class action over its Essure contraceptive, with a judge finding the evidence fell short of proving the device caused chronic inflammation.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?
error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au